JANUX THERAPEUTICS INC (JANX:NASDAQ)
$15.17 -0.41 (-2.6316%)
Analysed JANUX THERAPEUTICS INC (JANX:NASDAQ) News Sources
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
23-05-2026
fool.com
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch
23-05-2026
fool.com
Here's Why You Should Add JANX Stock to Your Portfolio Now
26-05-2026
yahoo.com
Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know
28-05-2026
yahoo.com
VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC
28-05-2026
yahoo.com
Akari Therapeutics Highlights 1st ASCO Abstract Acceptance
28-05-2026
yahoo.com
Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?
30-06-2026
yahoo.com
VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone
02-07-2026
yahoo.com
Is Janux Therapeutics’ (JANX) Russell Index Exit Quietly Rewriting Its Investor Base and Story?
09-07-2026
yahoo.com
3 Small-Cap Biotech Stocks Pairing Rapid Revenue Growth With High Insider Ownership
24-07-2026
yahoo.com
What is the current price of JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The current price of JANUX THERAPEUTICS INC (JANX:NASDAQ) is $15.17.
JANUX THERAPEUTICS INC (JANX:NASDAQ) absolute price change since previous trading day?
The absolute price change of JANUX THERAPEUTICS INC (JANX:NASDAQ) since the previous trading day is $-0.41.
JANUX THERAPEUTICS INC (JANX:NASDAQ) percentage price change since previous trading day?
The percentage price change of JANUX THERAPEUTICS INC (JANX:NASDAQ) since the previous trading day is -2.6316%.
What is the most recent average sentiment score for JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The most recent average sentiment score for JANUX THERAPEUTICS INC (JANX:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The most recent sentiment for JANUX THERAPEUTICS INC (JANX:NASDAQ) is .
SEC-8K** Filing Available For JANUX THERAPEUTICS INC (JANX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.